Overview
Congenital tracheal stenosis (CTS) is a rare congenital malformation characterized by narrowing of the trachea (windpipe) that is present from birth. The narrowing is most commonly caused by complete cartilaginous tracheal rings, where the normal C-shaped tracheal cartilages are replaced by O-shaped (complete) rings, eliminating the flexible posterior membranous wall of the trachea. This results in a fixed, rigid narrowing of the airway that can range from a short segment to involvement of the entire length of the trachea (long-segment tracheal stenosis). The condition primarily affects the respiratory system and can be life-threatening if severe. Key symptoms include stridor (noisy breathing), respiratory distress, wheezing, recurrent respiratory infections, cyanosis (bluish discoloration of the skin), and difficulty feeding. Symptoms may be present from birth or may become apparent in the first weeks to months of life, often worsening during respiratory infections when airway swelling further compromises the already narrowed trachea. The severity of symptoms depends on the degree and length of the stenosis. Congenital tracheal stenosis is frequently associated with other congenital anomalies, particularly cardiovascular malformations such as pulmonary artery sling (where the left pulmonary artery aberrantly courses between the trachea and esophagus), as well as other airway, cardiac, and gastrointestinal anomalies. Diagnosis is typically made through bronchoscopy and imaging studies such as CT angiography. Treatment depends on the severity and extent of the stenosis. Mild cases may be managed conservatively with close monitoring. Moderate to severe cases, particularly long-segment stenosis, typically require surgical intervention. The slide tracheoplasty has become the gold standard surgical technique, in which the stenotic trachea is divided, and the two halves are slid over each other to create a shorter but wider airway. This procedure has significantly improved outcomes compared to older techniques such as pericardial patch tracheoplasty. Outcomes have improved substantially in specialized centers, though the condition still carries significant morbidity and mortality, particularly in neonates with severe stenosis and associated anomalies.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital tracheal stenosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital tracheal stenosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital tracheal stenosis.
Community
No community posts yet. Be the first to share your experience with Congenital tracheal stenosis.
Start the conversation →Latest news about Congenital tracheal stenosis
No recent news articles for Congenital tracheal stenosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital tracheal stenosis
What is Congenital tracheal stenosis?
Congenital tracheal stenosis (CTS) is a rare congenital malformation characterized by narrowing of the trachea (windpipe) that is present from birth. The narrowing is most commonly caused by complete cartilaginous tracheal rings, where the normal C-shaped tracheal cartilages are replaced by O-shaped (complete) rings, eliminating the flexible posterior membranous wall of the trachea. This results in a fixed, rigid narrowing of the airway that can range from a short segment to involvement of the entire length of the trachea (long-segment tracheal stenosis). The condition primarily affects the re
How is Congenital tracheal stenosis inherited?
Congenital tracheal stenosis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital tracheal stenosis typically begin?
Typical onset of Congenital tracheal stenosis is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital tracheal stenosis?
4 specialists and care centers treating Congenital tracheal stenosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.